New sales powered Swedish oncology firm Elekta to healthy growth in its year-end fiscal year 2009 results (end-April 30).
The Stockholm-based firm reported an 18% increase in net sales to 6.69 billion kronor ($869.6 million U.S.) in fiscal year 2009 compared to 2008. Net profit advanced to 546 million kronor ($70.9 million U.S) in fiscal year 2009 over fiscal year 2008.
The company also projected that net sales for fiscal year 2010 will increase by more than 8%, with operating profit gaining more than 35%.
Related Reading
Elekta signs Ottawa Hospital, May 27, 2009
Elekta, Nucletron ink Mosaiq deal, May 19, 2009
Elekta nabs U.S. GPO contract, April 23, 2009
Elekta lands Neuromag install, April 17, 2009
Elekta installs Perfexion in Japan, February 26, 2009
Copyright © 2009 AuntMinnie.com
